Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice
Introduction Vaccines to prevent important infections involving, e.g. influenza viruses, severe acute respiratory syndrome-causing coronaviruses (e.g. SARS-CoV-2), respiratory syncytial viruses (RSV), and human immunodeficiency viruses (HIV) have remained insufficiently effective or are not availabl...
Saved in:
Main Authors: | Richard Voellmy, David C Bloom, Nuria Vilaboa |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2459751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01) -
Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
by: Yongqiang Zhao, et al.
Published: (2025-01-01) -
A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing
by: Jiao Zhang, et al.
Published: (2025-01-01) -
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01) -
The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases
by: Mohammed Al Ghobain, et al.
Published: (2025-01-01)